Loading...
Vivos Inc.
RDGL•PNK
Healthcare
Medical - Devices
$0.13
$-0.00(-0.23%)
Vivos Inc. (RDGL) Financial Performance & Income Statement Overview
Review Vivos Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
43.56%
↑ 43.56%
Operating Income Growth
6.76%
↑ 6.76%
Net Income Growth
-0.54%
↓ 0.54%
Operating Cash Flow Growth
-30.24%
↓ 30.24%
Operating Margin
-5753.61%
↓ 5753.61%
Gross Margin
-21.03%
↓ 21.03%
Net Profit Margin
-6342.39%
↓ 6342.39%
ROE
-156.74%
↓ 156.74%
ROIC
-90.72%
↓ 90.72%
Vivos Inc. (RDGL) Income Statement & Financial Overview
Review Vivos Inc.'s (RDGL) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $4995.00 | $5000.00 | $13500.00 | $4500.00 |
Cost of Revenue | $10280.00 | $3919.00 | $10780.00 | $97125.00 |
Gross Profit | -$5285.00 | $1081.00 | $2720.00 | -$92625.00 |
Gross Profit Ratio | -$1.06 | $0.22 | $0.20 | -$20.58 |
R&D Expenses | $100969.00 | $66551.00 | $99662.00 | $57447.00 |
SG&A Expenses | $555546.00 | $692275.00 | $334739.00 | $427057.00 |
Operating Expenses | $656515.00 | $844226.00 | $525029.00 | $484504.00 |
Total Costs & Expenses | $666795.00 | $848145.00 | $535809.00 | $581629.00 |
Interest Income | $19612.00 | $17882.00 | $18851.00 | $18590.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $0.00 | $10780.00 | $577129.00 |
EBITDA | -$661800.00 | -$843145.00 | -$511529.00 | $0.00 |
EBITDA Ratio | -$132.49 | -$168.63 | -$37.89 | $0.00 |
Operating Income | -$661800.00 | -$843145.00 | -$522309.00 | -$577130.00 |
Operating Income Ratio | -$132.49 | -$168.63 | -$38.69 | -$128.25 |
Other Income/Expenses (Net) | -$361388.00 | $17882.00 | $18852.00 | $18590.00 |
Income Before Tax | -$1.02M | -$825263.00 | -$503457.00 | -$558539.00 |
Income Before Tax Ratio | -$204.84 | -$165.05 | -$37.29 | -$124.12 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | -$577129.00 |
Net Income | -$1.02M | -$825263.00 | -$503457.00 | -$558539.00 |
Net Income Ratio | -$204.84 | -$165.05 | -$37.29 | -$124.12 |
EPS | -$0.003 | -$0.002 | -$0.001 | -$0.001 |
Diluted EPS | -$0.003 | -$0.002 | -$0.001 | -$0.001 |
Weighted Avg Shares Outstanding | $420.85M | $418.63M | $403.38M | $389.41M |
Weighted Avg Shares Outstanding (Diluted) | $420.85M | $418.63M | $403.38M | $389.41M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan